Chronic Stress Biomarkers for Early Detection and Prevention of Burnout

Project Information

SOMA Analytics

Grant agreement ID: 663269

DOI

10.3030/663269

Project closed

EC signature date 27 January 2015

Start date 1 December 2014

End date 31 May 2015

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 71 429,00

EU contribution

€ 50 000,00

Coordinated by

SOMA ANALYTICS UG (HAFTUNGSBESCHRANKT)
Germany

Periodic Reporting for period 1 - SOMA Analytics (Chronic Stress Biomarkers for Early Detection and Prevention of Burnout)

Reporting period: 2014-12-01 to 2015-05-31

Summary of the context and overall objectives of the project

The project validated the technical and commercial feasibility of a non-obtrusive smartphone-based solution that is able to recognise patterns of well-being and stress for the early detection and prevention of burnout based on the analysis of speech, sleep and typing behaviour.

The project has established the market interest (competitive analysis, willingness to pay) and recruited corporate organizations willing to participate in trials.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

Summary of Key Results:
-------------------

• Presented at industry conferences and generated interest from commercial and industrial partners
• Recruited early adopter companies from different sectors across Europe
• Mapped the competitive landscape and refined SOMA’s unique selling proposition
• Gathered market data on pricing and willingness to pay

It is worth mentioning that SOMA Analytics was named best eHealth solution produced by a European SME 2015 by the eHealth Competition, endorsed by the European Commission.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

Corporate wellbeing programmes are primarily reactive services (e.g. hotline counselling services) that are not scalable and have limited impact. In order to reduce costs and increase effectiveness, corporations are looking for solutions that allow employees to proactively manage their own health and well-being.

In 2013, the costs of work-related depression in the EU-27 was estimated to be €617 billion annually34, taking in account costs to employers resulting from absenteeism (€272 billion), loss of productivity (€242 billion), healthcare costs (€63 billion) and social welfare costs (€39 billion).

ehealthcompetition-cropped.jpg